Pub. Date : 2016 Oct
PMID : 27663902
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase. | 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid | ATP citrate lyase | Homo sapiens |
| 2 | Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase. | 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid | ATP citrate lyase | Homo sapiens |
| 3 | Bempedoic acid (ETC-1002), a novel therapeutic approach for low-density lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme involved in fatty acid and cholesterol synthesis. | 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid | ATP citrate lyase | Homo sapiens |
| 4 | Bempedoic acid (ETC-1002), a novel therapeutic approach for low-density lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme involved in fatty acid and cholesterol synthesis. | 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid | ATP citrate lyase | Homo sapiens |
| 5 | Bempedoic acid (ETC-1002), a novel therapeutic approach for low-density lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme involved in fatty acid and cholesterol synthesis. | 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid | ATP citrate lyase | Homo sapiens |
| 6 | Bempedoic acid (ETC-1002), a novel therapeutic approach for low-density lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme involved in fatty acid and cholesterol synthesis. | 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid | ATP citrate lyase | Homo sapiens |